Medications / Cancer & immunosuppressants
pembrolizumab
Cancer & immunosuppressants · RxNorm 1547545
Drug classes
- ANTINEOPLASTIC AGENTS (L01)
- MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES (L01F)
- PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors (L01FF)
May treat
- Mesothelioma, Malignant
- Biliary Tract Neoplasms
- Urinary Bladder Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Renal Cell
- Carcinoma, Squamous Cell
- Carcinoma, Transitional Cell
- Uterine Cervical Neoplasms
- Esophageal Neoplasms
- Carcinoma, Hepatocellular
- Hodgkin Disease
- Melanoma
- Stomach Neoplasms
- Ureteral Neoplasms
- Urethral Neoplasms
- Colorectal Neoplasms